These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11306584)

  • 1. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer.
    Lynch KW; Weiss A
    J Biol Chem; 2001 Jun; 276(26):24341-7. PubMed ID: 11306584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput analysis revealed mutations' diverging effects on
    Souček P; Réblová K; Kramárek M; Radová L; Grymová T; Hujová P; Kováčová T; Lexa M; Grodecká L; Freiberger T
    RNA Biol; 2019 Oct; 16(10):1364-1376. PubMed ID: 31213135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A disease-associated polymorphism alters splicing of the human CD45 phosphatase gene by disrupting combinatorial repression by heterogeneous nuclear ribonucleoproteins (hnRNPs).
    Motta-Mena LB; Smith SA; Mallory MJ; Jackson J; Wang J; Lynch KW
    J Biol Chem; 2011 Jun; 286(22):20043-53. PubMed ID: 21507955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HnRNP L represses exon splicing via a regulated exonic splicing silencer.
    Rothrock CR; House AE; Lynch KW
    EMBO J; 2005 Aug; 24(15):2792-802. PubMed ID: 16001081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides.
    Balestra D; Barbon E; Scalet D; Cavallari N; Perrone D; Zanibellato S; Bernardi F; Pinotti M
    Hum Mol Genet; 2015 Sep; 24(17):4809-16. PubMed ID: 26063760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of 5' splice-sites through multiple exonic motifs by hnRNP L.
    Loh TJ; Choi N; Moon H; Jang HN; Liu Y; Zhou J; Zheng X; Shen H
    Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):363-373. PubMed ID: 28119102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons.
    Tong A; Nguyen J; Lynch KW
    J Biol Chem; 2005 Nov; 280(46):38297-304. PubMed ID: 16172127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HnRNP L and L-like cooperate in multiple-exon regulation of CD45 alternative splicing.
    Preussner M; Schreiner S; Hung LH; Porstner M; Jäck HM; Benes V; Rätsch G; Bindereif A
    Nucleic Acids Res; 2012 Jul; 40(12):5666-78. PubMed ID: 22402488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing of a myosin phosphatase targeting subunit 1 alternative exon is regulated by intronic cis-elements and a novel bipartite exonic enhancer/silencer element.
    Dirksen WP; Mohamed SA; Fisher SA
    J Biol Chem; 2003 Mar; 278(11):9722-32. PubMed ID: 12509424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4.
    Topp JD; Jackson J; Melton AA; Lynch KW
    RNA; 2008 Oct; 14(10):2038-49. PubMed ID: 18719244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
    Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
    Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial control of signal-induced exon repression by hnRNP L and PSF.
    Melton AA; Jackson J; Wang J; Lynch KW
    Mol Cell Biol; 2007 Oct; 27(19):6972-84. PubMed ID: 17664280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling splicing outcome by combining 5'ss strength and splicing regulatory elements.
    Müller L; Ptok J; Nisar A; Antemann J; Grothmann R; Hillebrand F; Brillen AL; Ritchie A; Theiss S; Schaal H
    Nucleic Acids Res; 2022 Aug; 50(15):8834-8851. PubMed ID: 35947702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.
    Zheng ZM; Reid ES; Baker CC
    J Virol; 2000 Nov; 74(22):10612-22. PubMed ID: 11044105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer.
    Nielsen KB; Sørensen S; Cartegni L; Corydon TJ; Doktor TK; Schroeder LD; Reinert LS; Elpeleg O; Krainer AR; Gregersen N; Kjems J; Andresen BS
    Am J Hum Genet; 2007 Mar; 80(3):416-32. PubMed ID: 17273963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.
    Lemaire R; Winne A; Sarkissian M; Lafyatis R
    Eur J Immunol; 1999 Mar; 29(3):823-37. PubMed ID: 10092085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle-specific exonic splicing silencer for exon exclusion in human ATP synthase gamma-subunit pre-mRNA.
    Hayakawa M; Sakashita E; Ueno E; Tominaga S; Hamamoto T; Kagawa Y; Endo H
    J Biol Chem; 2002 Mar; 277(9):6974-84. PubMed ID: 11744705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conserved signal-responsive sequence mediates activation-induced alternative splicing of CD45.
    Rothrock C; Cannon B; Hahm B; Lynch KW
    Mol Cell; 2003 Nov; 12(5):1317-24. PubMed ID: 14636588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing.
    Heyd F; Lynch KW
    Mol Cell; 2010 Oct; 40(1):126-37. PubMed ID: 20932480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Context-dependent regulatory mechanism of the splicing factor hnRNP L.
    Motta-Mena LB; Heyd F; Lynch KW
    Mol Cell; 2010 Jan; 37(2):223-34. PubMed ID: 20122404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.